All Posts Tagged With: "FDA"
Clinical Trial Recruitment | Retention Issues for Manufacturers of Diabetes Agents
Clinical Trial Recruitment | Retention
Anxiety lurks among manufacturers of type 2 diabetes drugs, especially those manufacturers who have drugs in late clinical development.
Recent FDA advisory committee recommendations have created an ongoing debate over whether Investigational diabetes agents should be subject to long-term cardiovascular safety. 1 A firm consensus has not been reached, however, several manufacturers [...]
FDA Patient Safety News- Recalls and Safety Alerts: Serious Fungal Infections with Humira, Cimzia, Enbrel and Remicade November 1, 2008
- Recalls and Safety Alerts: Serious Injection Site Reactions with Vivitrol November 1, 2008
- Recalls and Safety Alerts: Updated Warning on Byetta November 1, 2008
- Recalls and Safety Alerts: Importance of Influenza Vaccination for Health Care Personnel November 1, 2008
- Recalls and Safety Alerts: Increased Risk of Death in Elderly Patients Taking Conventional Antipsychotics for Dementia November 1, 2008
